SEGLUROMET 7.5 mg/1

Segluromet 7.5 mg/1 combines ertugliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

Segluromet 7.5 mg/1 is used to help manage type 2 diabetes in adults. It works by improving blood sugar control, often alongside diet and exercise. This combination medication targets insulin resistance and glucose absorption, making it a common choice for those requiring dual-action therapy.

Common effects of Segluromet 7.5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea. Some users also report increased urination due to the medication's mechanism of action. These effects vary by individual and typically subside as the body adjusts.

Segluromet 7.5 mg/1 should be used with caution in individuals with kidney issues or a history of lactic acidosis. It is important to stay hydrated and monitor blood sugar levels regularly. Consult a healthcare provider before starting this medication, especially if you have other medical conditions.

Segluromet 7.5 mg/1 may interact with certain medications, including diuretics, blood pressure drugs, and other diabetes treatments. Alcohol can also affect its efficacy and increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.